spacer
home > ebr > spring 2019 > ecoa technology in vaccine clinical trials
PUBLICATIONS
European Biopharmaceutical Review

eCOA Technology in Vaccine Clinical Trials

Immunisation is one of the most successful and cost-effective public health interventions, protecting individuals against several serious, preventable, and sometimes, deadly contagious diseases, with a common example being the measles, mumps, and rubella vaccine. As essential as they are for preventative healthcare, vaccines are facing challenges in clinical trials and the industry is responsible for moving them faster through the process.

Vaccine developments face similar challenges to other therapeutic areas such as processing large volumes of manual data, which can be costly, time-consuming, and inefficient. Additionally, vaccine clinical trials often have aggressive timelines, and sponsors require a cost-effective and robust solution for data collection. By integrating electronic clinical outcome assessment (eCOA) with existing technologies, researchers can reduce the burden for study teams, increase patient compliance and retention, and improve overall study outcomes quickly. Making the switch from traditional paperbased processes to an eCOA solution in a vaccine trial can offer many tangible benefits.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Katie Garner is the Therapeutic Areas Advisor at CRF Bracket. She is responsible for providing specific therapeutic advice and supporting the therapeutic, sales, marketing and product development teams. Previously, Katie worked as a Project Manager for a Health Outcomes Consultancy and at the NHS Purchasing and Supply Agencies Centre for Evidence-Based Purchasing. She also worked for the Medicine and Healthcare products Regulatory Agency as a Senior Medical Device Specialist, where she was responsible for the safety and regulation of in vitro diagnostic and contraceptive medical devices.
spacer
Katie Garner
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Maetrics appoints Dr Amie Smirthwaite to lead Clinical Practice discipline globally

Maetrics, an international leader in life sciences quality and regulatory consulting, has appointed Dr Amie Smirthwaite as Senior Director of the Global Clinical Practice.
More info >>

White Papers

Running Smarter Trials With Data-Driven Monitoring

PAREXEL

Clinical monitoring remains one of the most important and most costly activities in the clinical research paradigm.  Monitoring provides the operational transparency required by investigators, sponsors, and regulators to make informed decisions about site performance, patient safety, and overall study progress. Yet unlike many clinical trial activities, which have been steadily transformed by technology, the monitoring function itself has changed little.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement